Vaginal atrophy

There are 61 papers on vaginal atrophy in aging research: 19 trials and 3 observational studies in people, 9 in animals, 1 in cells, 25 reviews. The newest story, Oct 11, 2026: “Vaginal estrogen changed bacterial communities after menopause”.

Disease

61 papers study it25 more mention it16 findings

3 new papers in 30 daysSee all 86 papers on vaginal atrophy

  • Human trial19
  • Humans3
  • Animals9
  • Cells1

Interventions

11

Dehydroepiandrosterone

downin humans2downin rats1

3 studies
  1. Dehydroepiandrosterone decreases vaginal atrophy in humans.

    “local daily intravaginal DHEA administration at DHEA doses of 3.25-13 mg was able to rapidly and efficiently achieve correction of all the signs and symptoms of vaginal atrophy”

    Human trialovules3.25-13 mg12 weeksfemalesn = 218

    Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

    Menopause (New York, N.Y.)

  2. Dehydroepiandrosterone decreases vaginal atrophy in postmenopausal estrogen-deficient women.

    “vaginally administered DHEA may improve vaginal atrophy with concomitant improvements in sexual function in women who are estrogen deficient due to menopause.”

    Reviewin postmenopausal estrogen-deficient womenvaginal

    DHEA for postmenopausal women: a review of the evidence

    Maturitas

  3. Dehydroepiandrosterone decreases vaginal atrophy in rats (ovariectomized rats) (Complete reversal).

    “resulted in a complete reversal of the vaginal atrophy seen 1, 3 and 6 months after ovariectomy”

    Animalsovariectomized ratsvagina30 mg twice daily1, 3 and 6 months

    Effect of dehydroepiandrosterone on vaginal and uterine histomorphology in the rat

    The Journal of steroid biochemistry and molecular biology

More on Dehydroepiandrosterone

Phoenix dactylifera

downin humans1

1 study
  1. Phoenix dactylifera decreases vaginal atrophy in humans (climacteric and menopause).

    “dates (Phoenix dactylifera L.) emerge as an accessible nutritional alternative rich in minerals and phytoestrogens, helping to combat vaginal atrophy and dryness.”

    Reviewclimacteric and menopausevaginafemales

    The role of nursing and integrative practices in the management of climacteric and menopausal symptoms: a literature review

    Revista fisio&terapia.

More on Phoenix dactylifera

Silybum marianum

downin mice1

1 study
  1. Silybum marianum decreases vaginal atrophy in mice (VCD-induced menopause).

    “In vivo, WS dose-dependently increased measured estradiol levels, increased uterine weight, and reversed vaginal atrophy.”

    AnimalsVCD-induced menopausewater-soluble complex prepared with steviol glycoside using microwave-assisted processingvaginal epitheliumfemales

    Enhanced Estrogenic Activity in Water-Soluble Silybum marianum Complex via Microwave-Assisted Steviol Glycoside-Based Formulation

    Nutrients

More on Silybum marianum

3-fluoro 6,4'-dihydroxyflavone

downin rats1

1 study
  1. 3-fluoro 6,4'-dihydroxyflavone decreases vaginal atrophy in rats (ovariectomized model of menopause).

    “Vaginal administration of this flavone regenerates the structure of atrophic vaginal epithelium.”

    Animalsovariectomized model of menopausesuppositoryvaginal epitheliumfemales

    Regeneration of the structure and function of estrogen-deficient vaginal epithelium by a novel phytoestrogen-related compound

    Menopause (New York, N.Y.)

More on 3-fluoro 6,4'-dihydroxyflavone

Umbilical cord mesenchymal stem cell-derived exosomes

downin rats1

1 study
  1. Umbilical cord mesenchymal stem cell-derived exosomes decrease vaginal atrophy in ovariectomized rats.

    “We examined the therapeutic effect of ucMSC-ex injection on vaginal atrophy in ovariectomized rats.”

    Animalsin ovariectomized ratsvaginal tissue

    Regenerative Effect of Vaginal Injections of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Ovariectomized Rats

    Aesthetic plastic surgery

More on Umbilical cord mesenchymal stem cell-derived exosomes

Vaginal microbiota transplantation

downin mice1

1 study
  1. Vaginal microbiota transplantation decreases vaginal atrophy in ovariectomized mice.

    “Vaginal transplantation of microbiota from ovary-intact mice significantly alleviated the vaginal atrophy of ovariectomized mice”

    Animalsin ovariectomized micefrom ovary-intact micevaginafour weeksfemales

    Vaginal microbiota transplantation alleviates vaginal atrophy in ovariectomized mice

    Scientific reports

More on Vaginal microbiota transplantation

Tocopherol

downin humans1

1 study
  1. Tocopherol decreases vaginal atrophy in humans (pre- and postmenopausal women).

    “distressing symptoms of vaginal atrophy, such as dryness, itching, and pain during intercourse, were resolved post-treatment.”

    Human trialpre- and postmenopausal womenovulesvagina500 mg per ovuletwo weeksfemalesn = 50

    Retrospective Investigator-Initiated Trial on Tocopherol Acetate Vaginal Administration in Pre-and Postmenopausal Women

    Diseases (Basel, Switzerland)

More on Tocopherol

Cell-free fat extract

downin mice1

1 study
  1. Cell-free fat extract decreases vaginal atrophy in ovariectomized mice.

    “CEFFE-treated mice showed increased mucosal thickness and number of vaginal mucosal cell layers and reduced vaginal atrophy compared to ovariectomized mice.”

    Animalsin ovariectomized micevagina2 weeksfemales

    Cell-Free Fat Extract Prevents Vaginal Atrophy in an Ovariectomized Model by Promoting Proliferation of Vaginal Keratinocytes and Neovascularization

    Aesthetic surgery journal

More on Cell-free fat extract

Lipofilling + platelet-rich plasma

downin humans1

1 study
  1. Lipofilling + platelet-rich plasma decreases vaginal atrophy in humans (refractory to estrogen cream).

    “Lipofilling with PRP relieved the clinical symptoms.”

    Human trialrefractory to estrogen creamautologous fat mixed with PRPlabia majora40 ccfemales

    Rejuvenation Using Platelet-rich Plasma and Lipofilling for Vaginal Atrophy and Lichen Sclerosus

    Journal of menopausal medicine

More on Lipofilling + platelet-rich plasma

Estriol

downin humans1

1 study
  1. Estriol decreases vaginal atrophy in humans (vaginal atrophy).

    “vaginal atrophy is treated with the intravaginal application of preparations containing estradiol or estriol, which are both effective and safe”

    Reviewvaginal atrophy

    Vaginal DHEA to treat menopause related atrophy: a review of the evidence

    Maturitas

More on Estriol

All 11

Associations

3

Estrogen deficiency

upin humans1

1 study
  1. Estrogen deficiency raises the risk of vaginal atrophy in humans.

    “and is due to an estrogen deficiency.”

    Review

    Standards of care and future directions in vaginal atrophy

    Pelviperineology

More on Estrogen deficiency

Punica granatum

downin mice1

1 study
  1. Punica granatum is associated with vaginal atrophy in mice following ovariectomy.

    “In a pre-clinical murine model following ovariectomy, improved bone formation and reduced vaginal atrophy were associated with pomegranate treatment.”

    Reviewfollowing ovariectomyvagina

    Beneficial Effects of Pomegranate Extracts for Benign Gynecologic Disorders

    Reproductive sciences (Thousand Oaks, Calif.)

More on Punica granatum

HIV infection

upin humans1

1 study
  1. Vaginal atrophy raises the risk of HIV infection in humans (mucosal disruption accompanying vaginal atrophy).

    “in women, an increased risk of HIV acquisition due to the mucosal disruption that accompanies vaginal atrophy”

    Reviewmucosal disruption accompanying vaginal atrophyfemales

    Menopause care in women living with HIV in the UK - A review

    Journal of virus eradication

More on HIV infection

Trial sponsors

Funding

4 grants since 2020

National Institute on Aging$1.3MEuropean Innovation Council€2.5MNational Institute of Allergy and Infectious Diseases$131K

Latest

Dec 2025: 2Jan 2026: 3Feb 2026: 4Mar 2026: 3Apr 2026: 2May 2026: 0Jun 2026: 1Jul 2026: 2Aug 2026: 4Sep 2026: 3Oct 2026: 3Nov 2026: 027 papers in 12 months

See all 86 papers on vaginal atrophy